The Case for Embracing the FDA’s Endorsed Data Standards

Provided By:

Chiltern

March 6, 2017

In this white paper, we’ll discuss the guidances compelling organizations to compile data into standardized, digital datasets, the FDA’s motivation behind these changes and the benefits to — as well as the hopes of — the organizations that must submit standardized data.

There is also a related podcast on this topic, which you can listen to using the below link.

Post a Comment

You must be logged in to post a Comment.

FEEDBACK